There is a general belief by clinicians that point-ofcare testing (POCT) will allow more timely treatment of their patients, and one particular metric used to assess this is turn-around time for laboratory results and the impact on length of stay in the emergency department (ED). Storrow et al 1 comment that POCT in ED has not been universally adopted even though easy-to-use instruments are widely available, analytical performance has improved, and various guidelines support their use. In their simulation model they show a potential decrease in ED length of stay from an average of 2.77 hours when a test is performed in 120 minutes to 2.17 hours if the test is performed in 10 minutes. However, actual proof of decrease in ED length of stay with POCT use has been elusive. Publications from the Netherlands and the United States report that the number of tests ED providers seek to make decisions is limited ❚Table 1❚.
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1,2 A survey of heads of biochemistry laboratories in the United Kingdom asked what was the optimal turn-around time for tests from receipt in the laboratory to results and what turn-around time they considered endangered patient safety. 3 For the ED, less than 1 hour was considered acceptable while above 2 hours was considered unacceptable. Both ED providers and laboratory directors are in agreement that short turn-around time of selected tests is better for patients. Thus, selected POCT can be of value if agreed upon turn-around times cannot be met. In the following discussion we present how, in the same ED, certain POCT can work but others do not work at all.
Our Experience
In our hospital the core laboratory is three buildings away and two floors up from the ED and it makes sense that bringing specimens over is problematic, even with a functional pneumatic tube system. The ED has the following POCT available: glucose meters, international normalized ratio (INR) devices, urine pregnancy testing, blood gases, and troponin measurement. These POCT are overseen for regulatory requirements and operated by different groups.
The POCT glucose and INR devices are operated by nursing staff and a group of medical technologists facilitates regulatory compliance of the use of these devices, including performing linearities, comparisons, and competency training when needed. The INR POCT is primarily dedicated to patients that come in with a presentation concerning for stroke, while the use of glucose meters has many indications. The glucose and INR devices lock out operators if quality controls are not run as specified and if someone that has not kept their competency tries to use the device. The use of POCT glucose devices has been embraced by nursing staff with minimal problems; however, we have had issues maintaining competency by nursing staff with the use of the INR device. On one occasion, a patient with a stroke needed evaluation and there was nobody in the ED that had maintained their competency to measure the INR, thus prompting a runner to bring the specimen to the core laboratory.
The urine pregnancy tests are primarily indicated for patients that require radiologic studies. These tests are performed by radiology personnel and managed by the POCT laboratory group. By trial and error, an efficient system to obtain urine samples for the pregnancy tests was finally established, giving timely results so that radiologic studies can be carried out. Regulatory compliance has been a bit more problematic, particularly entering quality control and patient results in the charts correctly. This prompted the need for devices that read the reaction and can be interfaced to the laboratory information system. The blood gas instruments are operated and managed by respiratory therapists. The group of respiratory therapists working in the ED obtain samples and run them in a small bench-top device. This group is outstanding in all regulatory aspects of the blood gas analysis, in addition to providing respiratory care for the ED patients.
In this setting, and after a chest pain accreditation program inspection strongly suggested having POCT for troponin measurement available in the ED for timely care, the POCT laboratory group was asked to evaluate the different devices that could be used. A comparison between the core laboratory platform and three POCT instruments that could be used in the ED, showed that the POCT instrument that yielded the best results was a small, bench-top instrument. After several meetings with ED nursing, physicians, and respiratory therapists, the instrument was acquired. The group decided that the instrument would be placed next to the blood gas instrument, and a workflow in which respiratory therapy and nursing would perform the test was established. For the first few months, the number of troponin tests performed was on average 15 per day, which was much less than the number of patients that required the test but proved that it could be done. Then, a push from ED and hospital leadership increased troponin POCT to an average of 70 tests per day. To our surprise, as the number of tests increased, the medical technologists that managed POCT started noting that we were having three to six mislabeled specimens per week. This was possible because the device interface system did not allow results to be reported for cases that had been discharged, and upon reviewing the clinical history, many of the patients with mislabeled specimens had not presented with chest pain. In addition, the time it took for patients to be discharged from the ED did not decrease even though the turn-around time for a troponin test run by the POCT was at least 20 minutes shorter compared to troponin measured in the core laboratory.
As you can imagine, the question of mislabeled specimens brought about a number of process improvements and helped to justify implementation of a positive patient identification system for the hospital and the entire system. It has also led to a practical end to troponin POCT in the ED. Some claim that having a bench-top instrument is not really POCT, although blood gases have been working well in the ED. On the other hand, the issues with competency with INR POCT when this device is used at the patient bedside, indicates that it is not really bench-top or bedside instruments that result in an effective use of POCT. Could the key to POCT that works for clinicians and laboratory, independent of type, be that the person reacting to the result should also perform the test? Glucose, blood gases, and urine pregnancy have worked. For these tests, the person that performs the test is the person reacting to the result and, for all, competencies are kept because they are performing these tests frequently. For glucose and blood gases, even the sample is obtained by the same person that will react to the results. In the case of urine pregnancy tests, obtaining the specimen was the problem, thus changing the workflow so that the urine is obtained as the patient arrives helped in providing results in time to get the patients into radiologic studies. Reasons why troponin and INR POCT do not work appear to be diverse and likely include workflow, low frequency of use, lack of confidence in the results obtained, and getting the result into the correct hands.
Conclusion
Our experience demonstrates an interesting duality. For troponin testing, misidentification of specimens has led to low confidence in results by clinicians but, from the laboratory perspective, this allowed us to place emphasis on the National Safety Goal of identifying patients correctly and has resulted in investment in a positive patient identification system to address the problem. 4 The low confidence in results has led to laboratory and ED dissatisfaction with having implemented an instrument that is not being used to its full potential. Our experience also showed that having POCT does not improve time for clinicians to act on results and discharge patients. Our experience in many ways is similar to a study of POCT in remote and rural EDs in Australia. 5 The authors commented on the disruptive potential of POCT, citing that there were challenges in workflow, that staff required appropriate training in interpretation of POCT results, and that implementation of POCT resulted in increased patient wait time as more testing was available. In the same study, comments by staff performing the tests cited that quality control for POCT was a time-intensive process, in addition to all the documentation needed for a variety of regulatory requirements such as checking refrigerator temperatures. In summary, even when in theory POCT can be of great help, it takes a lot more to define that the particular POCT will be successful. From our experience, it appears that those tests performed by the person that will take action on the results (blood gases, glucose, urine pregnancy) will work while the least successful POCT are the ones where the person that will act on the results is separate from the one performing the test.
